Cargando…
Characterization of mesenchymal stem cells in mucolipidosis type II (I-cell disease)
Mucolipidosis type II (ML-II, I-cell disease) is a fatal inherited lysosomal storage disease caused by a deficiency of the enzyme N-acetylglucosamine-1-phosphotransferase. A characteristic skeletal phenotype is one of the many clinical manifestations of ML-II. Since the mechanisms underlying these s...
Autores principales: | KÖSE, Sevil, AERTS KAYA, Fatima, KUŞKONMAZ, Barış, UÇKAN ÇETİNKAYA, Duygu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620033/ https://www.ncbi.nlm.nih.gov/pubmed/31320815 http://dx.doi.org/10.3906/biy-1902-20 |
Ejemplares similares
-
First allogeneic hematopoietic stem cell transplantation in RASGRP1 deficiency: long-term follow-up
por: Kuskonmaz, Baris, et al.
Publicado: (2022) -
Hyperthyroidism After Allogeneic Hematopoietic Stem Cell Transplantation: A Report of Four Cases
por: Sağ, Erdal, et al.
Publicado: (2015) -
Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells
por: Güney-Esken, Gülen, et al.
Publicado: (2021) -
Is hematopoietic stem cell transplantation a therapeutic option for mucolipidosis type II?
por: Ammer, Luise Sophie, et al.
Publicado: (2021) -
Pre-Conditioning Serum Uric Acid as a Risk Factor for Sinusoidal Obstruction Syndrome of the Liver in Children Undergoing Hematopoietic Stem Cell Transplantation
por: Visal Okur, Fatma, et al.
Publicado: (2021)